Compare · 2 funds side by side · dividends reinvested

TMED and XBI

TMEDT. Rowe Price×XBISPDR×

Versus in desk

Story of the two · Growth5Y$10,000 five years agoDividends reinvested · both on one scale$12,576XBI · best of the two

02 / 04

TMED and XBI, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

State Street SPDR S&P Biotech ETFSectors · Health care0.35%0.35%+27.2%+38.1%+34.5%+4.7%−14.9%29.1%$10.5B1.4

T. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Health Care ETFSectors · Health care0.44%0.47%+16.2%+21.3%[…][…]−11.1%18.7%$34M1.5

Rank among the two1st → 2ndFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 3, 2026 · returns include dividends · since: TMED 2025 · XBI 2006

Head to Head

Swap sides Versus in desk

Head to Head

T. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Health Care ETF · $34M[…]

TMED

XBI

State Street SPDR S&P Biotech ETF · $10.5B$12,576

$10,000 five years ago, dividends reinvested · they hold 16.1% in common

TMEDMeasureXBI

+16.2%Year to dateJan 1 → Nov 3+27.2%

+21.3%1 yearTotal return+38.1%

[…]3 years · per year$10,000 became […] · $24,320+34.5%

[…]5 years · per year$10,000 became […] · $12,576+4.7%

0.44%Expense ratio$44 · $35 a year on $10k · lower is better0.35%

0.47%Trailing 12-mo yield$47 · $35 a year on $10k0.35%

−11.1%Worst dropSmaller is better−14.9%

18.7%VolatilityLower is calmer29.1%

TMEDXBI Winner of the row, in its colourEach row: the bigger of the two fills its side

3–3Level

End-of-day Nov 3, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

TMED vs XBI: Top 5 Holdings

Today

TMED

22.3%in top 5

XBI

in top 59.7%

TMEDStockXBI

6.2%LLY.TOnot top 5

5.2%UNH.BAnot top 5

3.9%PODDnot top 5

3.6%ALNYnot top 5

3.4%TMO.TOnot top 5

not top 5MRNA2.4%

not top 5TWST2.0%

not top 5NTRA1.9%

not top 5HALO1.8%

not top 5BIIB1.7%

Held in common16.1%

End-of-day Nov 3, 2026 · share of each fund

TMED vs XBI Returns, Every Period

T. Rowe PriceTMED

+21.3%

past year

XBISPDR

+38.1%

past year

TMEDXBIFaded: behind in that period

0–2XBI wins

End-of-day Nov 3, 2026 · dividends in · faded = behind in that period

TMED vs XBI

YTD

T. Rowe PriceTMED

+16.2%

XBISPDR

+27.2%

+16.2%Year to date+27.2%

−11.1%Worst drop · 1Y−14.9%

18.7%Volatility · 1Y29.1%

0.5%Yield0.4%

$34.1MAssets$10.5B

3–1TMED wins

End-of-day Nov 3, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: TMED, XBI

Today

0.35%lowest, XBI

FundExpense ratioFee$10k

XBI0.35%$35

TMED0.44%$44

End-of-day Nov 3, 2026 · fee on $10,000 a year

Yields: TMED, XBI

0.47%highest, TMED

FundTrailing yieldYield$10k

TMED0.47%$47

XBI0.35%$35

End-of-day Nov 3, 2026 · trailing 12-month yield

Income After Fees on $10,000

$3most kept, TMED

TMED$47 − $44 = $3

XBI$35 − $35 = $0

KeptFee

End-of-day Nov 3, 2026 · yield in dollars minus the fee

Overlap: TMED, XBI

Today

16.1%most shared, TMED and XBI

TMEDXBI

TMED—16.1%

XBI16.1%—

End-of-day Nov 3, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 2 ETFs

+38.1%XBI, at 29.1% volatility

TMEDWorst drop−11.1%18.7% vol

XBIWorst drop−14.9%29.1% vol

End-of-day Nov 3, 2026 · up and left is better

Paid More vs Made More

YTD

TMEDXBI

+16.2%Year to date+27.2%

0.5%Yield0.4%

+21.3%Past year+38.1%

0.44%Fee0.35%

3–1XBI wins

End-of-day Nov 3, 2026

Popular Pairs Near These Two

SCHD vs VIG

YTD

SchwabSCHD

+32.8%

VIGVanguard

+14.0%

+32.8%Year to date+14.0%

3.0%Yield1.5%

$121BAssets$109B

2–0SCHD wins

End-of-day Nov 3, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+7.5%

JEPIJ.P. Morgan

+7.0%

+7.5%Year to date+7.0%

12.3%Yield8.0%

$41.8BAssets$46.0B

2–0JEPQ wins

End-of-day Nov 3, 2026

SPYM vs SPY

YTD

SPDRSPYM

+11.5%

SPYSPDR

+11.5%

+11.5%Year to date+11.5%

1.0%Yield1.0%

$185BAssets$798B

0–0level

End-of-day Nov 3, 2026